Evidence map›Paper›PMID 33874885›Full record

ArticleEnvironmental health and preventive medicine2021

Effect of IL-15 addition on asbestos-induced suppression of human cytotoxic T lymphocyte induction.

Naoko Kumagai-Takei, Yasumitsu Nishimura, Hidenori Matsuzaki, Suni Lee, Kei Yoshitome, Tatsuo Ito, Takemi Otsuki

Open access · goldAbstract read
In one paragraph

Article in Environmental health and preventive medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Naoko Kumagai-TakeiDepartment of Hygiene, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
Yasumitsu NishimuraDepartment of Hygiene, Kawasaki Medical School, Kurashiki, 701-0192, Japan. yas@med.kawasaki-m.ac.jp.ORCID http://orcid.org/0000-0002-3432-077X
Hidenori MatsuzakiDepartment of Hygiene, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
Suni LeeDepartment of Hygiene, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
Kei YoshitomeDepartment of Hygiene, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
Tatsuo ItoDepartment of Hygiene, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
Takemi OtsukiDepartment of Hygiene, Kawasaki Medical School, Kurashiki, 701-0192, Japan.
Kawasaki Medical School · JPPrefectural University of Hiroshima · JP

Funding

Japan Society for the Promotion of Science 16K09114Kawasaki Medical School 27B068Kawasaki Medical School 28B008
6 · The paper itself

Abstract

backgroundAsbestos fibers possess tumorigenicity and are thought to cause mesothelioma. We have previously reported that exposure to asbestos fibers causes a reduction in antitumor immunity. Asbestos exposure in the mixed lymphocyte reaction (MLR) showed suppressed induction of cytotoxic T lymphocytes (CTLs), accompanied by a decrease in proliferation of CD8

methodsFor MLR, human peripheral blood mononuclear cells (PBMCs) were cultured with irradiated allogenic PBMCs upon exposure to chrysotile B asbestos at 5 μg/ml for 7 days. After 2 days of culture, IL-15 was added at 1 ng/ml. After 7 days of MLR, PBMCs were collected and analyzed for phenotypic and functional markers of CD8

resultsIL-15 addition partially reversed the decrease in CD3

conclusionThese findings indicate that CTLs induced upon exposure to asbestos possess dysfunctional machinery that can be partly compensated by IL-15 supplementation, and that IL-15 is more effective in the recovery of proliferation and granzyme B levels from asbestos-induced suppression of CTL induction compared with IL-2.

Indexed as

AsbestosCD8-Positive T-LymphocytesHumansInterleukin-15Lymphocyte ActivationT-Lymphocytes, CytotoxicAsbestosInterleukin-15AsbestosCTLGranzyme BIL-15Proliferation

Identifiers

PMID33874885
PMCPMC8056682
OpenAlexW3152842877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.